Trials / Completed
CompletedNCT03143725
Study to Compare Bioavailability of GLPG1972 Given as 2 Different Tablet Formulations Versus an Oral Solution
Open-label Study to Compare the Bioavailability of an Oral Wet Granulation Tablet of GLPG1972 Relative to an Oral Solution and to an Oral Direct Compression Tablet After Single-dose Intake in Healthy Subjects, and to Evaluate the Effect of Food on the Bioavailability of an Oral Wet Granulation Tablet.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Galapagos NV · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This study is a Phase I, randomized, open-label, cross-over study with 4 single-dose treatments of GLPG1972 to compare the bioavailability of the oral wet granulation (WG) tablet relative to an oral solution and to the oral direct compression (DC) tablet after single dose intake in healthy male subjects and to evaluate the effect of food on the bioavailability of the WG oral tablet.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GLPG1972 | Oral administration of GLPG1972 in four different treatment conditions (Treatments A throug D) |
Timeline
- Start date
- 2017-04-14
- Primary completion
- 2017-06-06
- Completion
- 2017-06-06
- First posted
- 2017-05-08
- Last updated
- 2017-06-20
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03143725. Inclusion in this directory is not an endorsement.